Orthofix Medical Inc. (OFIX)
Largest Insider Buys in Sector
OFIX Stock Price History Chart
OFIX Stock Performance
About Orthofix Medical Inc.
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Insider Activity of Orthofix Medical Inc.
Over the last 12 months, insiders at Orthofix Medical Inc. have bought $101,025 and sold $0 worth of Orthofix Medical Inc. stock.
On average, over the past 5 years, insiders at Orthofix Medical Inc. have bought $679,885 and sold $427,732 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hinrichs James F. (director) — $303,075.
The last purchase of 7,500 shares for transaction amount of $101,025 was made by Hinrichs James F. (director) on 2023‑09‑14.
List of Insider Buy and Sell Transactions, Orthofix Medical Inc.
| 2023-09-14 | Hinrichs James F. | director | 7,500 0.0209% | $13.47 | $101,025 | +0.38% | ||
| 2023-05-26 | Sale | Kenny Kevin J. | President of Global Spine | 3,876 0.0109% | $19.00 | $73,644 | -26.41% | |
| 2023-05-24 | Sale | Kenny Kevin J. | President of Global Spine | 4,367 0.0124% | $19.00 | $82,973 | -26.13% | |
| 2023-03-10 | Sale | Maniar Shweta | director | 4,262 0.012% | $17.75 | $75,651 | -12.41% | |
| 2021-11-22 | Paolucci Michael E | director | 2,000 0.0098% | $31.15 | $62,300 | -15.70% | ||
| 2021-11-19 | DOUG RICE | CFO | 1,400 0.0069% | $30.05 | $42,070 | -12.36% | ||
| 2021-11-19 | BURZIK CATHERINE M | director | 1,660 0.0082% | $30.27 | $50,248 | -12.36% | ||
| 2021-11-18 | Serbousek Jon Carl | CEO | 1,670 0.0088% | $31.14 | $52,004 | -9.28% | ||
| 2021-11-18 | Elting Kimberley A. | Chief Legal & Develop. Officer | 1,000 0.0051% | $30.34 | $30,340 | -9.28% | ||
| 2020-06-05 | Sale | Finegan Michael | Chief Strategy Officer | 8,750 0.0454% | $37.41 | $327,323 | +1.54% | |
| 2020-03-16 | MATRICARIA RONALD A | director | 20,000 0.1056% | $24.25 | $485,000 | +41.92% | ||
| 2020-03-12 | Hinrichs James F. | director | 10,000 0.052% | $26.85 | $268,469 | +26.12% | ||
| 2020-02-27 | Serbousek Jon Carl | CEO | 2,900 0.015% | $35.48 | $102,895 | -6.27% | ||
| 2019-10-31 | MATRICARIA RONALD A | director | 20,000 0.1064% | $42.27 | $845,305 | -19.47% | ||
| 2019-08-28 | Sale | Mason Brad | CEO | 5,805 0.0307% | $50.97 | $295,874 | -28.03% | |
| 2019-06-13 | Sale | Mason Brad | CEO | 17,780 0.0937% | $51.11 | $908,654 | -11.87% | |
| 2019-05-14 | Sale | Mason Brad | CEO | 21,336 0.113% | $53.71 | $1.15M | -13.57% | |
| 2019-04-17 | Sale | Mason Brad | CEO | 11,898 0.0627% | $52.35 | $622,888 | -5.87% | |
| 2019-02-19 | Sale | Bianchi Davide | President, Global Extremities | 48,398 0.2562% | $65.00 | $3.15M | -21.76% | |
| 2019-02-15 | Sale | Bianchi Davide | President, Global Extremities | 402 0.0022% | $65.00 | $26,130 | -20.48% |
Insider Historical Profitability
| Hinrichs James F. | director | 86153 0.2344% | $13.22 | 3 | 0 | +20.2% |
| GAINES COOPER ROBERT | 10 percent owner | 353200 0.9609% | $13.22 | 0 | 23 | |
| Mason Brad | CEO | 165041 0.449% | $13.22 | 1 | 16 | <0.0001% |
| GERO JAMES | director | 156630 0.4261% | $13.22 | 9 | 0 | <0.0001% |
| MATRICARIA RONALD A | director | 154939 0.4215% | $13.22 | 5 | 0 | +12.76% |
| Kenny Kevin J. | President of Global Spine | 142431 0.3875% | $13.22 | 0 | 2 | |
| Serbousek Jon Carl | CEO | 112812 0.3069% | $13.22 | 2 | 0 | <0.0001% |
| MASON BRADLEY R | Global President,North America | 85000 0.2313% | $13.22 | 1 | 7 | <0.0001% |
| DOUG RICE | CFO | 73543 0.2001% | $13.22 | 1 | 3 | <0.0001% |
| Schumm Jeffrey | Chief Administrative Officer | 68882 0.1874% | $13.22 | 0 | 1 | |
| VATERS ROBERT S | President and CEO | 65616 0.1785% | $13.22 | 2 | 0 | +43.84% |
| HEWETT PETER J | director | 59800 0.1627% | $13.22 | 0 | 9 | |
| Finegan Michael | Chief Strategy Officer | 47933 0.1304% | $13.22 | 0 | 11 | |
| Elting Kimberley A. | Chief Legal & Develop. Officer | 46803 0.1273% | $13.22 | 1 | 1 | <0.0001% |
| Heggestad Mark A | Chief Financial Officer | 46696 0.127% | $13.22 | 1 | 0 | <0.0001% |
| LITTLECHILD JOHN W | director | 35861 0.0976% | $13.22 | 0 | 1 | |
| MILINAZZO ALAN | President & CEO | 28341 0.0771% | $13.22 | 11 | 0 | <0.0001% |
| GOODWIN ROBERT ALLEN II | President Biologics | 27920 0.076% | $13.22 | 0 | 1 | |
| Paolucci Michael E | director | 27141 0.0738% | $13.22 | 1 | 0 | <0.0001% |
| NIEMANN BRADLEY V. | President of Global Spine | 25361 0.069% | $13.22 | 0 | 5 | |
| Sainz Maria | director | 20828 0.0567% | $13.22 | 1 | 1 | +18.35% |
| Bianchi Davide | President, Global Extremities | 20666 0.0562% | $13.22 | 0 | 3 | |
| Maniar Shweta | director | 20080 0.0546% | $13.22 | 0 | 1 | |
| FERRARI LUIGI | President, Orthopedics | 15833 0.0431% | $13.22 | 0 | 10 | |
| WALLNER EDGAR | Deputy Chairman | 15800 0.043% | $13.22 | 1 | 17 | +23.06% |
| FUJIKAWA RAYMOND | President Spine Fixation | 12859 0.035% | $13.22 | 0 | 2 | |
| SCOON DAVEY | director | 10917 0.0297% | $13.22 | 0 | 1 | |
| HARTSUIKER FREDERIK | director | 8500 0.0231% | $13.22 | 0 | 3 | |
| BURZIK CATHERINE M | director | 7947 0.0216% | $13.22 | 1 | 0 | <0.0001% |
| WEISSHAAR KENNETH R | director | 7073 0.0192% | $13.22 | 2 | 0 | <0.0001% |
| Lee Brad | President, Sports Medicine GBU | 6481 0.0176% | $13.22 | 0 | 3 | |
| FAULSTICK LUKE T | director | 6479 0.0176% | $13.22 | 0 | 2 | |
| Mainelli Michael | director | 6419 0.0175% | $13.22 | 2 | 0 | +6.04% |
| Buxton Emily | Chief Financial Officer | 6039 0.0164% | $13.22 | 1 | 0 | <0.0001% |
| BROWN ERIC | President, Spinal Stimulation | 5000 0.0136% | $13.22 | 0 | 2 | |
| FEDERICO CHARLES | director | 4325 0.0118% | $13.22 | 0 | 19 | |
| Kester Thomas J | director | 4000 0.0109% | $13.22 | 3 | 0 | <0.0001% |
| HEIN THOMAS M | Vice President of Finance | 3641 0.0099% | $13.22 | 0 | 11 | |
| Kolls Raymond C | SVP, General Counsel | 3180 0.0087% | $13.22 | 5 | 0 | <0.0001% |
| Widensohler Stefan | director | 2000 0.0054% | $13.22 | 1 | 0 | +3.89% |
| DABREU DE PAUL ALBERTO C | director | 2000 0.0054% | $13.22 | 0 | 2 | |
| HENLEY GARY | President, Americas Division | 823 0.0022% | $13.22 | 0 | 11 | |
| BROWN ERIC M | Senior VP, Sales & Marketing | 441 0.0012% | $13.22 | 0 | 3 | |
| CLARKE PETER | Executive Vice President | 0 0% | $13.22 | 0 | 4 | |
| MOULD GALVIN | President, International Div | 0 0% | $13.22 | 0 | 2 |
Institutional Investor Ownership
| Armistice Capital Llc | $53.72M | 9.86 | 3.7M | +2.78% | +$1.45M | 0.64 | |
| Helm Capital Management LLC | $53.22M | 9.77 | 3.67M | 0% | +$0 | 1.57 | |
| BlackRock | $47.82M | 8.78 | 3.29M | -0.73% | -$349,772.28 | <0.01 | |
| Engine Capital Management Lp | $44.07M | 8.09 | 3.04M | 0% | +$0 | 8.9 | |
| Morgan Stanley | $40.07M | 7.35 | 2.76M | +31.86% | +$9.68M | <0.01 | |
| The Vanguard Group | $29.17M | 5.35 | 2.01M | +0.46% | +$132,858.00 | <0.01 | |
| Paradigm Capital Management Inc Ny | $28.27M | 5.19 | 1.95M | +107.94% | +$14.67M | 1.35 | |
| Newtyn Management | $18.46M | 3.39 | 1.27M | +20.71% | +$3.17M | 4.01 | |
| State Street | $15.49M | 2.84 | 1.07M | -8.31% | -$1.4M | <0.01 | |
| Boone Capital Management Llc | $14.15M | 2.6 | 974,502 | +94.9% | +$6.89M | 2.86 | |
| Glenview Capital Management | $12.82M | 2.35 | 883,125 | +76.63% | +$5.56M | 0.25 | |
| Geode Capital Management | $11.7M | 2.15 | 805,581 | +1.74% | +$200,043.37 | <0.01 | |
| Emerald Advisers, Inc. | $11.11M | 2.04 | 765,204 | +1.06% | +$116,421.29 | 0.45 | |
| Awm Investment Company Inc | $6.89M | 1.26 | 474,456 | 0% | +$0 | 1.02 | |
| Tejara Capital Ltd | $6.31M | 1.16 | 434,711 | +10.31% | +$589,744.35 | 2.14 | |
| Millennium Management LLC | $6.3M | 1.16 | 433,748 | -14.63% | -$1.08M | <0.01 | |
| EMERALD MUTUAL FUND ADVISERS TRUST | $5.73M | 1.05 | 394,662 | 0% | +$0 | 0.3 | |
| Jacobs Levy Equity Management | $5.68M | 1.04 | 391,327 | -39.46% | -$3.7M | 0.03 | |
| Northern Trust | $5.13M | 0.94 | 353,214 | -0.53% | -$27,544.44 | <0.01 | |
| Dimensional Fund Advisors | $4.98M | 0.91 | 342,642 | -25.2% | -$1.68M | <0.01 | |
| Charles Schwab | $4.12M | 0.76 | 283,622 | -38.59% | -$2.59M | <0.01 | |
| Clearline Capital LP | $3.76M | 0.69 | 259,194 | -19.29% | -$899,194.59 | 0.37 | |
| Jupiter Fund Management | $3.74M | 0.69 | 257,537 | -13.29% | -$573,191.48 | 0.01 | |
| Great Lakes Advisors® | $3.28M | 0.6 | 225,636 | -2% | -$67,038.82 | 0.03 | |
| Russell Investments Group Ltd | $3.21M | 0.59 | 221,309 | -5.42% | -$183,968.65 | 0.01 | |
| AREX Capital Management, LP | $3.19M | 0.59 | 220,000 | +328.28% | +$2.45M | 3.58 | |
| Algert Global LLC | $3.13M | 0.58 | 215,760 | -13.61% | -$493,517.20 | 0.12 | |
| Citadel Advisors LLC | $3.06M | 0.56 | 210,892 | -22.16% | -$871,577.56 | <0.01 | |
| Nuveen | $3.05M | 0.56 | 209,817 | -20.31% | -$776,471.56 | <0.01 | |
| Goldman Sachs | $2.89M | 0.53 | 198,895 | +44.56% | +$890,148.48 | <0.01 | |
| Voya Investment Management LLC | $2.78M | 0.51 | 191,554 | -10.51% | -$326,612.99 | <0.01 | |
| Mutual Of America Capital Management Llc | $2.55M | 0.47 | 175,671 | +15.31% | +$338,664.49 | 0.03 | |
| HighVista Strategies | $2.44M | 0.45 | 167,900 | New | +$2.44M | 0.9 | |
| Barclays | $2.29M | 0.42 | 157,777 | +46.97% | +$732,166.88 | <0.01 | |
| GAMCO Investors | $2.17M | 0.4 | 149,200 | +21.01% | +$376,068.00 | 0.02 | |
| Gabelli Funds Llc | $2.12M | 0.39 | 146,000 | +4.66% | +$94,380.00 | 0.02 | |
| BNY Mellon | $1.96M | 0.36 | 134,654 | -12.92% | -$290,139.67 | <0.0001 | |
| Cubist Systematic Strategies | $1.88M | 0.35 | 129,349 | -42.6% | -$1.39M | 0.02 | |
| Clough Capital Partners L.P. | $1.78M | 0.33 | 122,690 | -9.85% | -$194,713.22 | 0.2 | |
| Renaissance Technologies | $1.71M | 0.31 | 117,536 | -65.36% | -$3.22M | <0.01 | |
| Tudor Investment Corp Et Al | $1.39M | 0.26 | 95,797 | +104.92% | +$712,191.26 | 0.02 | |
| Jane Street Capital | $1.26M | 0.23 | 86,649 | -68.79% | -$2.77M | <0.01 | |
| Ubs Oconnor Llc | $1.22M | 0.22 | 84,249 | +4.98% | +$58,079.98 | 0.1 | |
| Man Group Plc | $1.19M | 0.22 | 81,651 | +663.09% | +$1.03M | <0.01 | |
| Invesco | $1.11M | 0.2 | 76,259 | +38.59% | +$308,302.97 | <0.0001 | |
| Kennedy Capital Management Inc | $1.03M | 0.19 | 71,203 | -0.37% | -$3,862.32 | 0.02 | |
| Deutsche Bank | $1.01M | 0.19 | 69,262 | +0.84% | +$8,378.04 | <0.0001 | |
| Engineers Gate Manager Lp | $989,262.00 | 0.18 | 68,131 | +39.17% | +$278,435.49 | 0.03 | |
| Swiss National Bank | $948,156.00 | 0.17 | 65,300 | -9.81% | -$103,092.00 | <0.01 | |
| Gsa Capital Partners Llp | $921,000.00 | 0.17 | 63,412 | New | +$921,000.00 | 0.07 |